Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MD Stock Summary
Top 10 Correlated ETFs
MD
In the News
MD Financial details
Company Rating
Neutral
Market Cap
777.3M
Income
-41.53M
Revenue
1.99B
Book val./share
10.11
Cash/share
2.12
Dividend
-
Dividend %
-
Employees
5.45K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
7.2
Forward P/E
-
PEG
-0.45
P/S
0.41
P/B
0.84
P/C
4.16
P/FCF
6.18
Quick Ratio
1.15
Current Ratio
1.2
Debt / Equity
0.83
LT Debt / Equity
0.78
-
-
EPS (TTM)
-0.48
EPS next Y
-
EPS next Q
-
EPS this Y
-191.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-44.58%
Revenue last 5Y
-10.71%
Revenue Q/Q
-2.01%
EPS Q/Q
-402.04%
-
-
-
-
SMA20
-1.5%
SMA50
-1.71%
SMA100
1.21%
Inst Own
79.02%
Inst Trans
0.8%
ROA
5%
ROE
12%
ROC
0.09%
Gross Margin
22%
Oper. Margin
9%
Profit Margin
6%
Payout
226%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7.7-15.06
52W High
-41.27%
52W Low
+25.86%
RSI
37.59
Rel Volume
0.39
Avg Volume
686.22K
Volume
267.35K
Perf Week
-7.75%
Perf Month
-0.34%
Perf Quarter
-25.72%
Perf Half Y
-30.85%
-
-
-
-
Beta
1.579
-
-
Volatility
0.28%, 0.3%
Prev Close
0%
Price
8.81
Change
-1.67%
MD Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 42.08 | 20.79 | 22.53 | 23.63 | 23.74 | |
Net income per share | -13.77 | -0.11 | 1.54 | 0.79 | -0.72 | |
Operating cash flow per share | 4.15 | 2.45 | 0.9 | 2 | 1.63 | |
Free cash flow per share | 3.77 | 2.11 | 0.52 | 1.64 | 1.24 | |
Cash per share | 2.24 | 14.73 | 5.74 | 1.23 | 2.12 | |
Book value per share | 17.95 | 8.97 | 10.57 | 10.68 | 10.11 | |
Tangible book value per share | -21.95 | -11.93 | -10.84 | -11.52 | -6.62 | |
Share holders equity per share | 17.95 | 8.97 | 10.57 | 10.68 | 10.11 | |
Interest debt per share | 23.52 | 23.22 | 13.64 | 9.5 | 8.85 | |
Market cap | 2.32B | 2.05B | 2.31B | 1.24B | 781.37M | |
Enterprise value | 4.03B | 2.73B | 2.99B | 1.98B | 1.41B | |
P/E ratio | -2.02 | -213.62 | 17.63 | 18.7 | -12.93 | |
Price to sales ratio | 0.66 | 1.18 | 1.21 | 0.63 | 0.39 | |
POCF ratio | 6.69 | 10 | 30.08 | 7.43 | 5.69 | |
PFCF ratio | 7.37 | 11.64 | 51.89 | 9.04 | 7.51 | |
P/B Ratio | 1.55 | 2.74 | 2.57 | 1.39 | 0.92 | |
PTB ratio | 1.55 | 2.74 | 2.57 | 1.39 | 0.92 | |
EV to sales | 1.15 | 1.57 | 1.56 | 1.01 | 0.71 | |
Enterprise value over EBITDA | 8.14 | 13.5 | 11.86 | 8.36 | 7.19 | |
EV to operating cash flow | 11.62 | 13.33 | 38.92 | 11.88 | 10.27 | |
EV to free cash flow | 12.8 | 15.51 | 67.14 | 14.46 | 13.56 | |
Earnings yield | -0.5 | 0 | 0.06 | 0.05 | -0.08 | |
Free cash flow yield | 0.14 | 0.09 | 0.02 | 0.11 | 0.13 | |
Debt to equity | 1.23 | 2.44 | 1.21 | 0.85 | 0.83 | |
Debt to assets | 0.44 | 0.55 | 0.4 | 0.32 | 0.32 | |
Net debt to EBITDA | 3.45 | 3.37 | 2.69 | 3.13 | 3.2 | |
Current ratio | 1.28 | 3.66 | 1.88 | 0.89 | 1.24 | |
Interest coverage | 3.49 | 1.57 | 2.95 | 4.35 | 0.17 | |
Income quality | -0.3 | -21.36 | 0.71 | 2.67 | -2.27 | |
Dividend Yield | 0.75 | 0.26 | 0 | 0 | 0.6 | |
Payout ratio | -1.52 | -54.93 | 0 | 0 | -7.78 | |
Sales general and administrative to revenue | 0.12 | 0.14 | 0.14 | 0.12 | 0.11 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.8 | 0.52 | 0.67 | 0.79 | 0.63 | |
Capex to operating cash flow | -0.09 | -0.14 | -0.42 | -0.18 | -0.24 | |
Capex to revenue | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | |
Capex to depreciation | -0.4 | -1.01 | -1 | -0.83 | -0.92 | |
Stock based compensation to revenue | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
Graham number | 74.59 | 4.81 | 19.16 | 13.82 | 12.79 | |
ROIC | 0.11 | -0.09 | 0.08 | 0.08 | 0.01 | |
Return on tangible assets | -1.41 | -0.01 | 0.14 | 0.13 | -0.07 | |
Graham Net | -24.98 | -14.27 | -13.11 | -13.55 | -11.62 | |
Working capital | 145.13M | 1.13B | 346.73M | -39.48M | 94.51M | |
Tangible asset value | -1.83B | -994.91M | -919.83M | -961.34M | -556.35M | |
Net current asset value | -1.99B | -1.05B | -1.09B | -1.12B | -887.3M | |
Invested capital | 1.23 | 2.44 | 1.21 | 0.85 | 0.83 | |
Average receivables | 520.57M | 370.4M | 271.85M | 299.28M | 288.33M | |
Average payables | 490.6M | 467.51M | 408.64M | 212.99M | 33.22M | |
Average inventory | 0.5 | 1 | 1 | 1 | 6.76M | |
Days sales outstanding | 51.82 | 50.93 | 57.63 | 54.93 | 51.21 | |
Days payables outstanding | 71.27 | 120.23 | 102.9 | 7.73 | 8.03 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 3.14 | |
Receivables turnover | 7.04 | 7.17 | 6.33 | 6.64 | 7.13 | |
Payables turnover | 5.12 | 3.04 | 3.55 | 47.24 | 45.48 | |
Inventory turnover | 2.62B | 1.28B | 1.4B | 1.5B | 116.31 | |
ROE | -0.77 | -0.01 | 0.15 | 0.07 | -0.07 | |
Capex per share | -0.38 | -0.35 | -0.38 | -0.36 | -0.4 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.19 | 6 | 6.08 | 6.14 | 5.91 | |
Net income per share | 0.36 | 0.17 | 0.34 | 0.49 | -1.48 | |
Operating cash flow per share | 1.19 | -1.23 | 1.08 | 0.97 | 0.82 | |
Free cash flow per share | 1.08 | -1.32 | 0.98 | 0.86 | 0.72 | |
Cash per share | 1.24 | 1.26 | 1.27 | 1.51 | 2.12 | |
Book value per share | 10.75 | 11.11 | 11.44 | 11.73 | 10.11 | |
Tangible book value per share | -11.59 | -11.42 | -7.36 | -7.02 | -6.62 | |
Share holders equity per share | 10.75 | 11.11 | 11.44 | 11.73 | 10.11 | |
Interest debt per share | 9.2 | 10.61 | 9.19 | 8.44 | 8.47 | |
Market cap | 1.23B | 1.22B | 1.17B | 1.05B | 781.37M | |
Enterprise value | 1.98B | 2.04B | 1.91B | 1.73B | 1.41B | |
P/E ratio | 10.39 | 21.49 | 10.35 | 6.51 | -1.57 | |
Price to sales ratio | 2.4 | 2.49 | 2.34 | 2.07 | 1.57 | |
POCF ratio | 12.49 | -12.1 | 13.15 | 13.12 | 11.28 | |
PFCF ratio | 13.75 | -11.31 | 14.47 | 14.82 | 12.98 | |
P/B Ratio | 1.38 | 1.34 | 1.24 | 1.08 | 0.92 | |
PTB ratio | 1.38 | 1.34 | 1.24 | 1.08 | 0.92 | |
EV to sales | 3.85 | 4.15 | 3.82 | 3.42 | 2.84 | |
Enterprise value over EBITDA | 30.33 | 51.69 | 32.98 | 58.47 | 29.02 | |
EV to operating cash flow | 20.03 | -20.19 | 21.46 | 21.7 | 20.36 | |
EV to free cash flow | 22.05 | -18.88 | 23.61 | 24.51 | 23.42 | |
Earnings yield | 0.02 | 0.01 | 0.02 | 0.04 | -0.16 | |
Free cash flow yield | 0.07 | -0.09 | 0.07 | 0.07 | 0.08 | |
Debt to equity | 0.85 | 0.94 | 0.79 | 0.73 | 0.83 | |
Debt to assets | 0.32 | 0.37 | 0.32 | 0.3 | 0.32 | |
Net debt to EBITDA | 11.42 | 20.72 | 12.77 | 23.11 | 12.93 | |
Current ratio | 0.89 | 1.38 | 1.24 | 1.2 | 1.24 | |
Interest coverage | 5.63 | 2.89 | 4.32 | -3.88 | -11.06 | |
Income quality | 4.11 | -7.1 | 3.15 | 3.74 | -0.56 | |
Dividend Yield | 0 | 0 | 0.18 | 0.05 | 0 | |
Payout ratio | 0 | 0 | 7.25 | 1.22 | 0 | |
Sales general and administrative to revenue | 0.1 | 0.12 | 0.12 | 0.11 | 0.11 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.79 | 0.8 | 0.67 | 0.67 | 0.63 | |
Capex to operating cash flow | -0.09 | 0.07 | -0.09 | -0.11 | -0.13 | |
Capex to revenue | -0.02 | -0.01 | -0.02 | -0.02 | -0.02 | |
Capex to depreciation | -0.99 | -0.78 | -0.91 | -0.99 | -1 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 9.3 | 6.58 | 9.4 | 11.35 | 18.34 | |
ROIC | 0.03 | 0.01 | 0.02 | 0.03 | -0.06 | |
Return on tangible assets | 0.06 | 0.03 | 0.04 | 0.05 | -0.15 | |
Graham Net | -13.63 | -13.41 | -12.74 | -12.36 | -11.62 | |
Working capital | -39.48M | 85.21M | 77.45M | 70.08M | 94.51M | |
Tangible asset value | -961.34M | -934.9M | -606.52M | -579.59M | -556.35M | |
Net current asset value | -1.12B | -1.1B | -965.37M | -937.83M | -887.3M | |
Invested capital | 0.85 | 0.94 | 0.79 | 0.73 | 0.83 | |
Average receivables | 300.43M | 287.76M | 274.8M | 274.1M | 278.62M | |
Average payables | 29.5M | 33.6M | 33.16M | 31.34M | 33.14M | |
Average inventory | 4.83M | 1 | 6.23M | 11.52M | 12.06M | |
Days sales outstanding | 51.98 | 51.09 | 48.7 | 49.27 | 50.74 | |
Days payables outstanding | 7.2 | 8.09 | 7.24 | 7.14 | 7.88 | |
Days of inventory on hand | 0 | 0 | 2.91 | 2.38 | 3.08 | |
Receivables turnover | 1.73 | 1.76 | 1.85 | 1.83 | 1.77 | |
Payables turnover | 12.49 | 11.12 | 12.43 | 12.61 | 11.43 | |
Inventory turnover | 398.04M | 392.96M | 30.91 | 37.76 | 29.23 | |
ROE | 0.03 | 0.02 | 0.03 | 0.04 | -0.15 | |
Capex per share | -0.11 | -0.09 | -0.1 | -0.11 | -0.11 |
MD Frequently Asked Questions
What is MEDNAX, Inc. stock symbol ?
MEDNAX, Inc. is a US stock , located in Sunrise of Fl and trading under the symbol MD
What is MEDNAX, Inc. stock quote today ?
MEDNAX, Inc. stock price is $8.81 today.
Is MEDNAX, Inc. stock public?
Yes, MEDNAX, Inc. is a publicly traded company.